Aimmune is the second initial public offering of stock this week from the Bay Area read more
Mary Rozenman ā Senior Vice President, Corporate Development and Strategy at Aimmune Therapeutics
Executive Bio
Mary Rozenman serves as the Senior Vice President, Corporate Development and Strategy of Aimmune Therapeutics. Mary started at Aimmune Therapeutics in February of 2016. Mary currently resides in the San Francisco Bay Area.
Executive Team Culture Ratings from Aimmune Therapeutics Employees
TOP
5%
Aimmune Therapeutics' Executive Team scores in the Top 5%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at Aimmune TherapeuticsNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at Aimmune TherapeuticsAimmune Therapeutics' Executive Team at a Glance
Based on 6 ratings, Aimmune Therapeutics' employees are very satisfied with their Executive Team and give them an āA+ā or 84/100.
Aimmune Therapeutics' Executive Team ranks in the Top 10% of other companies in San Francisco and Top 5% of other companies on Comparably that also have 1-10 Employees.
×